Patent · US Active

Incretin-insulin conjugates

US10232020B2 · kind B2 · utility

1Cited by

33References

19Claims

0Family size

Assignee

INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION · US

Inventors

Richard D. DiMarchi · Carmel, US
John Philip Mayer · Boulder, US
David L. Smiley · Greenfield, US
Fa Liu · Watchung, US

Key dates

Filing date	Sep 23, 2015
Grant date	Mar 19, 2019
Priority date	—
Expiry date	Sep 23, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are insulin agonist peptides conjugated to incretins wherein the incretin-insulin conjugate has agonist activity at the insulin receptor and the corresponding incretin receptor, and stimulates weight loss in an individual administered the compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.